肠道准备方案对前列腺癌图像引导放疗中分次间直肠充盈变化的影响
本研究回顾性分析80例接受前列腺±精囊放疗(78Gy/39次/8周,每日图像引导)的患者,比较抗胀气饮食联合氢氧化镁乳剂(MoM)与单纯抗胀气饮食对分次间直肠充盈变化的影响。
要点
- MoM联合抗胀气饮食未减少分次间直肠充盈变化。
- MoM组60%患者出现腹泻,40%患者因此停用。
- 单纯抗胀气饮食组腹泻发生率仅22.5%。
核心结论
- 在抗胀气饮食基础上加用MoM未能减少前列腺癌放疗中分次间直肠充盈变化,反而导致较高比例患者腹泻并停用。
研究设计与样本
- 回顾性识别两组各40例前列腺癌患者,均接受前列腺±精囊放疗(78Gy/39次/8周)并每日图像引导。
- 第一组采用抗胀气饮食并于计划CT前3天开始服用MoM直至放疗期间,第二组仅采用相同抗胀气饮食。
- 在计划CT和每周锥形束CT(CBCT)上勾画临床靶区(CTV)上下限之间的直肠,评估直肠充盈。
主要发现
- 共分析80例患者的720幅图像(80幅计划CT和640幅CBCT)。
- 采用线性混合模型调整计划CT时基线值后,两组8周治疗期间直肠体积(p=0.4)、横截面积(p=0.5)、CTV上水平(p=0.4)和中水平(p=0.4)直肠前后径均无显著差异。
- 非MoM组22.5%患者出现腹泻,MoM组为60%,且40%患者在放疗结束时停用MoM。
临床怎么用
- 不推荐在抗胀气饮食基础上常规加用MoM以期减少直肠充盈变化,因其无效且增加腹泻风险。
局限性
- 本研究为回顾性设计,样本量有限(每组40例),可能影响结果外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to investigate the tolerability and impact of milk of magnesia (MoM) on interfraction rectal filling during prostate cancer radiotherapy. METHODS: Two groups were retrospectively identified, each consisting of 40 patients with prostate cancer treated with radiotherapy to prostate+/-seminal vesicles, with daily image-guidance in 78Gy/39fractions/8 weeks. The first-group followed anti-flatulence diet with MoM started 3-days prior to planning-CT and continued during radiotherapy, while the second-group followed the same anti-flatulence diet only. The rectum between upper and lower limit of the clinical target volume (CTV) was delineated on planning-CT and on weekly cone-beam-CT (CBCT). Rectal filling was assessed by measurement of anterio-posterior diameter of the rectum at the superior and mid levels of CTV, rectal volume (RV), and average cross-sectional rectal area (CSA; RV/length). RESULTS: Overall 720 images (80 planning-CT and 640 CBCT images) from 80 patients were analyzed. Using linear mixed models, and after adjusting for baseline values at the time of planning-CT to test the differences in rectal dimensions between both groups over the 8-week treatment period, there were no significant differences in RV (p = 0.4), CSA (p = 0.5), anterio-posterior diameter of rectum at superior (p = 0.4) or mid level of CTV (p = 0.4). In the non-MoM group; 22.5% of patients had diarrhea compared to 60% in the MoM group, while 40% discontinued use of MoM by end of radiotherapy. CONCLUSION: The addition of MoM to antiflatulence diet did not reduce the interfraction variation in rectal filling but caused diarrhea in a substantial proportion of patients who then discontinued its use.
引用
- Hosni A, Rosewall T, Craig T, et al. The effect of bowel preparation regime on interfraction rectal filling variation during image guided radiotherapy for prostate cancer. Radiat Oncol. 2017. PMID: 28279179. doi:10.1186/s13014-017-0787-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。